Nuveen Asset Management LLC grew its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,356,298 shares of the company's stock after buying an additional 23,237 shares during the period. Nuveen Asset Management LLC owned approximately 0.95% of Oscar Health worth $31,669,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC increased its stake in shares of Oscar Health by 217.5% in the 3rd quarter. Barclays PLC now owns 325,818 shares of the company's stock valued at $6,911,000 after acquiring an additional 223,189 shares in the last quarter. Rolek Wealth Management LLC acquired a new stake in Oscar Health in the fourth quarter worth $208,000. Janney Montgomery Scott LLC increased its stake in Oscar Health by 24.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company's stock valued at $778,000 after purchasing an additional 11,282 shares in the last quarter. Whalen Wealth Management Inc. bought a new stake in Oscar Health in the fourth quarter valued at $670,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in shares of Oscar Health by 28.2% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company's stock valued at $295,000 after purchasing an additional 4,838 shares during the period. 75.70% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts have recently commented on OSCR shares. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research note on Thursday, May 22nd. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of "Hold" and a consensus target price of $20.08.
Read Our Latest Report on OSCR
Oscar Health Stock Up 5.1%
Shares of Oscar Health stock traded up $0.72 on Tuesday, hitting $14.89. The company had a trading volume of 2,825,631 shares, compared to its average volume of 4,306,593. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a 50 day moving average of $13.68 and a 200-day moving average of $14.59. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of -745.43 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the company posted $0.62 earnings per share. Oscar Health's revenue was up 42.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Insider Transactions at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 24.39% of the company's stock.
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.